Search

everythinglearnresearchcommunity

for

Search:↓

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

ALRN-6924 may prevent hair loss caused by chemotherapy.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Different types of dog hair loss are linked to problems starting the hair growth phase and early hair cycle ending.

Some horses lose hair without inflammation or itching due to various conditions, and while mainly a cosmetic issue, diagnosis requires examination and biopsies, and breeding is not advised if it's hereditary.

Trichotillometry is a reliable method to measure hair strength and assess hair loss treatments.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

Transplanted rat hair follicles grew hair and had increased but not fully restored nerve connections in mice.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

Understanding hair follicle anatomy helps diagnose hair disorders.

Systemic diseases can cause hair loss, which is often reversible with treatment.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Laser hair removal is now more effective, but the best treatment schedule is still uncertain.

The absence of functional sebaceous glands causes hair follicle destruction and scarring alopecia.

Skin lymphatic vessels are essential for hair growth.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Using a special laser can improve how well hair loss treatments get into the skin and hair follicles.

A new model using mice with human hair follicles helps better understand hair loss from chemotherapy.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Sorafenib may cause hair loss in a way similar to alopecia areata.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.